Last reviewed · How we verify
NCT06176820: VHAL
Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause
Phase 2, PHASE3 trial testing Vaginal Gel in Menopause Related Conditions in 52 participants. Status unknown.
1 July 2024
Quick facts
| Lead sponsor | Sarawak General Hospital |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 52 |
| Start date | 1 January 2024 |
| Primary completion | 1 July 2024 |
| Estimated completion | 1 July 2024 |
Drugs / interventions tested
- Vaginal Gel
- Vaginal lubricant
Conditions studied
- Menopause Related Conditions — all drugs for Menopause Related Conditions →
- Atrophic Vaginitis — all drugs for Atrophic Vaginitis →
- Genitourinary Syndrome of Menopause — all drugs for Genitourinary Syndrome of Menopause →
- Sexual Dysfunction — all drugs for Sexual Dysfunction →
Sponsor
Sarawak General Hospital
Who can join
Adults 40 to 80, female only, with Menopause Related Conditions or Atrophic Vaginitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this interventional study is to compare the efficacy and safety of vaginal hyaluronic acid, arginine and liposome gel versus vaginal lubricant in the treatment of genitourinary syndrome of menopause in postmenopausal women. The main question it aims to answer is: Is vaginal hyaluronic acid, arginine and liposome gel more effective than vaginal lubricant in the treatment of genitourinary syndrome of menopause in postmenopausal women Participants will be randomized into 2 treatment groups: vaginal hyaluronic acid, arginine and liposome group and vaginal lubricant group. Researchers will compare whether vaginal hyaluronic acid, arginine and liposome group has better improvement than vaginal lubricant group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06176820
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vaginal Gel
Trials testing the same drug.
- NCT03116022 — Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women · Phase 1 · completed
Other recruiting trials for Menopause Related Conditions
Currently open trials in the same condition.
- NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
- NCT06497270 — A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY Trial · NA · active not recruiting
- NCT07182370 — Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause). · NA · active not recruiting
- NCT04031456 — Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients · Phase 2, PHASE3 · recruiting
Other Sarawak General Hospital trials
Trials by the same sponsor.
- NCT05939726 — Efficacy and Safety of Moisturising Cream With or Without Vitamin E and Urea Cream in Palmar-plantar Erythrodysesthesia · NA · completed
- NCT05935696 — A Prospective Observational Study on the Role of Transthoracic Ultrasound in Differentiating Tuberculous From Malignant · unknown
- NCT05599633 — Effect of Sago-based Product on Glycaemic and Lipid Control in Diabetes · NA · completed
- NCT05082467 — Prolonged Cardiac ECG Patch Versus Conventional Holter For Detecting Atrial Fibrillation After Cerebral Ischemic Event · active not recruiting
- NCT03459599 — Antibiotic Prophylaxis in Ragged Placental Membranes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06176820 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sarawak General Hospital
- Last refreshed: 28 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06176820.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing